LM

Leena Mittal

Active Director Director DIN 07507738
DIN 07507738 First appointment May 2016 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2016
Shareholding value •••• Premium profile

About Leena Mittal

Data last updated:

Leena Mittal is a Director at Kiaora Pharmaceuticals Private Limited (since 2016). The company operates in Trading. Kiaora Pharmaceuticals Private Limited reported revenue of ₹63.3 Lakh (FY 2025).

DIN 07507738
Primary Designation Director
Industry Trading
First Appointment 10 May 2016
Oldest Company Age 20 yrs
Largest company Kiaora Pharmaceuticals Private Limited · ₹63.3 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director10 May 20162005₹63.3 Lakh (FY 2025)Active

Board colleagues of Leena Mittal

Directorship timeline

Open interactive timeline →
Kiaora Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Leena Mittal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Leena Mittal

Leena Mittal currently holds 1 directorship: Kiaora Pharmaceuticals Private Limited (Director, since 10 May 2016, revenue ₹63.3 Lakh (FY 2025)).

Leena Mittal was first appointed on 10 May 2016 as Director at Kiaora Pharmaceuticals Private Limited.

The current boards of Leena Mittal's companies include Pradumn Kumar Mittal (Kiaora Pharmaceuticals Private Limited), Shivam Mittal (Kiaora Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available